A National Government will pay for 13 cancer treatments that are helping extend survival rates in Australia, by making them available to patients in New Zealand, National Leader Christopher Luxon says.
Treatments for cancer will soon be at the same level as those used on HIV and COVID-19, says David Thomas, principal research fellow and chief executive of Australian genomic cancer medicine centre Omico
A Feilding pharmacist has sold his share of a Whanganui pharmacy and is biking more than 6000 kilometres around the country to raise money for two causes close to his heart
Virginia McMillan follows up on the cancer-drug trial she first reported in 2017, when patients with glioblastoma were being recruited to test a regimen of repurposed drugs
As Life Pharmacy Prices’ Nikki Welsh faces a stage-four cancer diagnosis, her staff of 61 are fundraising via a givealittle page to provide financial support to her family while they spend as much time with her as possible, Paulette Crowley reports
As Life Pharmacy Prices’ Nikki Welsh faces a stage-four cancer diagnosis, her staff of 61 are fundraising via a givealittle page to provide financial support to her family while they spend as much time with her as possible
We are on our summer break and the editorial office is closed until 17 January. In the meantime, please enjoy our Summer Hiatus series, an eclectic mix from our news and clinical archives and articles from The Conversation throughout the year
Christchurch pharmacist Sarah Mooney takes a look at the most common cancers in New Zealand – skin cancers – then discusses what you can do to promote prevention in community pharmacy
Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes